文献速递头颈外科

多机构可行性导入试验:99m锝硫胶体SPECT-CT淋巴绘图评估偏侧口咽癌对侧病变

A multi-institutional feasibility lead-in trial of lymphatic mapping with SPECT-CT for evaluating contralateral disease in lateralized oropharynx cancer using 99m-technetium sulfur colloid.
PubMed 文献 · Head Neck · 2024-07-17

该多机构可行性导入试验纳入12例接受根治性或辅助放疗的偏侧口咽癌(T1-T3)成人患者,注射99m锝硫胶体后行平面淋巴显像验证示踪剂迁移,并在30±15分钟(可选)和3小时(±1小时,强制时间点)行SPECT-CT。所有患者完成研究,无示踪剂迁移失败,无严重不良事件或并发症;4/12例(33%)显示对侧引流模式。结论:偏侧口咽鳞状细胞癌的SPECT-CT淋巴绘图可在多机构安全实施。

要点

  • 12例偏侧口咽癌患者均完成SPECT-CT淋巴绘图,无示踪剂迁移失败。
  • 4/12例(33%)显示对侧引流模式,无严重不良事件或并发症。
  • 7/12例在局部麻醉下注射,5例需全身麻醉。

核心结论

  • 偏侧口咽鳞状细胞癌的SPECT-CT淋巴绘图可在多机构安全实施。

研究设计与样本

  • 多机构可行性导入试验,纳入12例计划接受根治性或辅助放疗、无对侧淋巴结病变的偏侧口咽癌(T1-T3)成人患者。

主要发现

  • 所有12例患者完成研究,7/12例在局部麻醉下注射,5例需全身麻醉。
  • 无示踪剂迁移失败,无严重不良事件或并发症。
  • 4/12例(33%)显示对侧引流模式。

关键数值与推荐

  • 注射99m锝硫胶体后行静态平面淋巴显像验证示踪剂迁移,SPECT-CT在30±15分钟(可选)和3小时(±1小时,强制时间点)采集。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymphatic mapping with SPECT-CT has been demonstrated to accurately define lymphatic drainage patterns in oropharyngeal cancer but there has yet to be a study demonstrating its feasibility across multiple institutions. METHODS: Twelve adult patients with lateralized oropharyngeal carcinoma (T1-T3) who were planned for definitive or adjuvant radiotherapy without contralateral nodal disease underwent injection of 99-m technetium sulfur colloid followed by static planar lymphoscintigraphy to verify tracer migration, and SPECT-CT acquired at 30 ± 15 min (optional) and 3 h (±1 h) (mandatory time-point). RESULTS: All 12 patients completed the study with 7/12 patients having the injections performed under local anesthetic and 5 patients requiring general anesthetic. There were no tracer migration failures and there were no serious adverse events or complications encountered. Four out of 12 patients (33%) showed contralateral drainage patterns. CONCLUSIONS: Lymphatic mapping with SPECT-CT of lateralized oropharyngeal squamous cell carcinoma can be performed safely across multiple institutions.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Sarkis LM, Yao CM, Hendler A, et al. A multi-institutional feasibility lead-in trial of lymphatic mapping with SPECT-CT for evaluating contralateral disease in lateralized oropharynx cancer using 99m-technetium sulfur colloid. Head Neck. 2024. PMID: 39016220. doi:10.1002/hed.27871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。